Riskpilot← Back to searchSign inGet full accessMedilens Holding AB
ABActiveOrg 5566905096HelsingborgEconomic activity was not specified by tax authority · NACE 0000Est. 20050 employees
Revenue 2024
SEK 0
EBITDA margin
—
-17% vs 2023
Equity ratio
99.4%
Financial strength
Net profit 2024
SEK 1,2M
-88% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -330K | -17% |
| Net profit | SEK 1,2M | -88% |
| Total assets | SEK 61,8M | -12% |
| Equity | SEK 61,4M | -13% |
| Employees | 0 | — |
Legal name
Medilens Holding AB
Org number
5566905096
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
15 november 2005
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva försäljning och distribution av sjukvårds- och läkemedelsprodukter, äga och förvalta aktier och värdepapper samt därmed förenlig verksamhet.
Address
Helsingborg
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −185 | −225 | −248 | −283 | −330 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −185 | −225 | −248 | −283 | −330 |
| Net financials | 20 650 | 20 467 | 21 324 | 10 652 | 1 892 |
| Profit before tax | 20 465 | 20 242 | 21 076 | 10 369 | 1 562 |
| Tax | −100 | −63 | −237 | −89 | −335 |
| Net profit | 20 365 | 20 179 | 20 839 | 10 280 | 1 227 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 41 510 | 54 734 | 69 719 | 70 517 | 61 757 |
| Equity | 41 354 | 54 533 | 67 872 | 70 152 | 61 379 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 156 | 201 | 1 847 | 365 | 378 |
| Total debt | 156 | 201 | 1 847 | 365 | 378 |
EBITDA margin
-33000000.0%
This company
15.8%
Market median
-208860859% vs market
20202024
Equity ratio
99.4%
This company
38.2%
Market median
+160% vs market
20202024
Return on equity
2.0%
This company
18.4%
Market median
-89% vs market
20202024
Net profit margin
122700000.0%
This company
8.1%
Market median
+1514814715% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KM Chief Auditor | Chief Auditor | 2025 |
| Former (1) | ||
PO Audit | Audit | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Medilens Holding AB (this company)
Medilens Nordic ABBoard members of Medilens Holding AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Martin Erlandsson | Chief Auditor | 0 companies |
| Pär Olle Lövgren | Audit | 0 companies |
| Ulla Agneta Törner | Board of Directors | 0 companies |
| Bo Martin Forssell | Deputy Board Member | 0 companies |